Radioligand binding techniques in human myocardial membranes demonstrate varying beta-1 and beta-2 receptor selectivities among different beta-blockers, offering a precise method to evaluate receptor affinity.
No takes yet. Share an insight, caveat, or question.
Should not guide beta-blocker selection in practice; leaves open clinical validation of subtype-specific effects.
Golf et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: